Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Oct 9, 2026, 11:21 AM EST
Waverley Pharma Market Cap
Waverley Pharma has a market cap or net worth of CAD 540 thousand as of October 9, 2026. It is the 50,560th most valuable company in the world and the 2,623rd biggest in Canada. Its market cap has decreased by 50.00% in one year.
Market Cap
540.00K
Enterprise Value
4.10M
Revenue
1.17M
Global Rank
Country Rank
#2,623 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 27, 2017, Waverley Pharma's market cap has decreased from 27.00M to 540.00K, a decrease of -98.00%. That is a compound annual growth rate of -35.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 540.00K | -50.00% |
| Dec 22, 2025 | 1.08M | 100.00% |
| Dec 31, 2024 | 540.00K | -60.00% |
| Dec 22, 2023 | 1.35M | -16.67% |
| Dec 28, 2022 | 1.62M | -62.50% |
| Dec 30, 2021 | 4.32M | -36.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 3.54M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 1.59M |
| Universal Ibogaine | 1.56M |
| Doseology Sciences | 961.40K |
| MindBio Therapeutics | 946.80K |
| Vaxil Bio | 577.68K |